|1.||Carrington, Mary: 10 articles (12/2014 - 09/2002)|
|2.||Ståhle, Mona: 9 articles (08/2015 - 01/2005)|
|3.||Moffett, Ashley: 8 articles (09/2015 - 10/2004)|
|4.||Bowcock, Anne M: 6 articles (12/2015 - 04/2004)|
|5.||Trowsdale, John: 6 articles (01/2015 - 09/2002)|
|6.||Capon, Francesca: 6 articles (01/2013 - 03/2002)|
|7.||Trembath, Richard C: 6 articles (01/2013 - 09/2002)|
|8.||Mallbris, Lotus: 6 articles (11/2010 - 08/2003)|
|9.||Parham, Peter: 5 articles (11/2015 - 11/2010)|
|10.||Kuśnierczyk, Piotr: 5 articles (04/2015 - 01/2003)|
10/01/2014 - "Recently, HLA-C expression levels were shown to be correlated with protection against multiple outcomes of HIV-1 infection; however, the underlying mechanisms are poorly understood. "
04/01/2010 - "KIR and HLA-C protection in both treatment response and spontaneously resolving HCV was validated at the allelic level, in which KIR2DL3-HLA-Cw*03 was associated with SVR (P = 0.004, OR = 3.4, 95% CI = 1.5-8.7) and KIR2DL3/KIR2DL3-HLA-Cw*03 was associated with spontaneous resolution of HCV infection (P = 0.01, OR = 2.3, 95% CI = 1.2-4.4). "
01/01/2009 - "In this study, we have identified the major histocompatibility complex class I C molecule (HLA-C) as an attachment factor in facilitating HCoV-HKU1 spike (S)-mediated infection. "
10/01/2015 - "In cohorts of human patients, resolution of HCV infection has been associated with homozygosity for both C1(+)HLA-C and its cognate inhibitory receptor, KIR2DL3. "
01/01/2015 - "Genome-wide association studies (GWASs) have revealed several genetic loci associated with HIV-1 outcome following infection (e.g., HLA-C at 6p21.33) in multi-ethnic populations with genetic heterogeneity and racial/ethnic differences among Caucasians, African-Americans, and Hispanics. "
03/01/1999 - "The aim of this investigation was to compare the frequency of alleles at the HLA-C locus in patients with psoriatic arthritis to that in the disease free population and to relate the HLA genes to disease phenotype in psoriatic arthritis (PsA). "
12/01/2014 - "Significance of association of HLA-C and HLA-E with psoriatic arthritis."
01/01/2014 - "The Region Centromeric to HLA-C Is a Key Region for Understanding the Phenotypic Variability of Psoriatic Arthritis."
01/01/2006 - "HLA-C locus alleles may modulate the clinical expression of psoriatic arthritis."
12/01/2005 - "HLA-C locus alleles distribution in patients from northern Poland with psoriatic arthritis--preliminary report."
|3.||Melanoma (Melanoma, Malignant)
08/15/2006 - "Therefore, the goal of this study was to investigate the involvement of early changes in CD8 T cells and CD56 natural killer (NK) cells expressing NK receptors in different HLA-C dimorphism groups of melanoma patients. "
05/01/2013 - "For this purpose, KIR genotyping by PCR-SSP and HLA-C genotyping by reverse PCR-SSO were performed in 187 melanoma patients and 200 matched controls. "
08/15/2006 - "Natural killer receptors on CD8 T cells and natural killer cells from different HLA-C phenotypes in melanoma patients."
01/01/2006 - "Remarkably, individuals homozygous for group 2 HLA-C alleles (HLA-C(Lys80)) seem to be associated with metastatic progression of melanoma. "
01/01/2006 - "Moreover, the influence of HLA-C on melanoma has not yet been well established. "
|4.||Graft vs Host Disease (Graft-Versus-Host Disease)
08/01/2000 - "Sequential analysis of HLA-C-specific killer cell inhibitory receptor (CD158b) expressing peripheral blood mononuclear cells during chronic graft-versus-host disease."
12/01/1995 - "Five of nine patients who received BMT from HLA-C mismatched unrelated donors developed > grade II graft-vs.-host disease (GVHD), and four developed graft rejection. "
12/18/2014 - "Life-threatening graft-versus-host disease (GVHD) limits the use of HLA-C-mismatched unrelated donors in transplantation. "
01/01/2014 - "HLA-C mismatches are clearly associated to alloreactivity after hematopoietic stem-cell transplantation; in a number of large cohorts, HLA-C mismatches are correlated to an increased risk of acute graft-versus-host disease (GVHD) or even impaired survival. "
11/01/1996 - "In the unrelated BMT group, the transplant-related complications of mortality, graft-versus-host disease (GVHD), and graft rejection, were significantly higher in molecular HLA-C mismatched than matched patients (67% vs 14%, P < 0.02; 50% vs 7%, P < 0.02; 42% vs 0, P < 0.02). "
|5.||HIV Infections (HIV Infection)
04/05/2013 - "We characterized the differential cell surface expression levels of all common HLA-C allotypes and tested directly for effects of HLA-C expression on outcomes of HIV infection in 5243 individuals. "
10/01/2012 - "Two polymorphisms affecting HLA-C surface expression (rs9264942 and rs67384697) have recently been identified, and shown to influence progression of HIV infection. "
05/01/2012 - "This is, to our knowledge, the first in vivo evidence supporting the protective role of HLA-C-restricted responses in nonwhites during HIV infection."
11/01/2010 - "The potential importance of HLA-C-restricted CD8+ cytotoxic T lymphocytes (CTL) in HIV infection remains undetermined. "
04/01/2010 - "Characterization of an HLA-C-restricted CTL response in chronic HIV infection."
|1.||HLA-B Antigens (HLA-B)
|2.||HLA-A Antigens (HLA-A)
|3.||HLA-DRB1 antigen (HLA DRB1)
|6.||HLA-DQB1 antigen (HLA DQB1)
|8.||HLA-DQ Antigens (HLA-DQ)
|9.||HLA-DP Antigens (HLA-DP)
|10.||Dihydrotachysterol (AT 10)
|2.||Homologous Transplantation (Allograft)
|3.||Bone Marrow Transplantation (Transplantation, Bone Marrow)
|4.||Highly Active Antiretroviral Therapy (HAART)
|5.||Transplantation (Transplant Recipients)